KPIs & Operating Metrics(New)
Growth Metrics

Johnson & Johnson (JNJ) Total Debt (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 29, 2026 14.72%
Dec 28, 2025 4.67%
Sep 28, 2025 -9.78%
Jun 29, 2025 -2.85%
Mar 30, 2025 42.63%
Dec 29, 2024 2.47%
Sep 29, 2024 -13.83%
Jun 30, 2024 23.37%
Mar 31, 2024 14.66%
Dec 31, 2023 -1.97%
Oct 1, 2023 -34.39%
Jul 2, 2023 -13.81%
Apr 2, 2023 33.46%
Jan 1, 2023 23.78%
Oct 2, 2022 -1.75%
Jul 3, 2022 -1.66%
Apr 3, 2022 -1.79%
Jan 2, 2022 -0.52%
Oct 3, 2021 1.33%
Jul 4, 2021 -0.39%
Apr 4, 2021 -4.69%
Jan 3, 2021 180.38%
Sep 27, 2020 -58.62%
Jun 28, 2020 10.19%
Mar 29, 2020 -0.41%
Dec 29, 2019 -5.21%
Sep 29, 2019 -0.68%
Jun 30, 2019 0.17%
Mar 31, 2019 -3.65%
Dec 30, 2018 -2.47%
Sep 30, 2018 -2.59%
Jul 1, 2018 -1.38%
Apr 1, 2018 -5.92%
Dec 31, 2017 -1.66%
Oct 1, 2017 1.72%
Jul 2, 2017 6.80%
Apr 2, 2017 19.33%
Jan 1, 2017 0.51%
Oct 2, 2016 2.84%
Jul 3, 2016 12.39%
Apr 3, 2016 17.56%
Jan 3, 2016 0.56%
Sep 27, 2015 2.29%
Jun 28, 2015 1.71%
Mar 29, 2015 1.19%
Dec 28, 2014 22.88%
Sep 28, 2014 -10.83%
Jun 29, 2014 -0.98%
Mar 30, 2014 -4.88%
Dec 29, 2013 20.34%
Sep 29, 2013 0.83%
Jun 30, 2013 -5.73%
Mar 31, 2013 -1.69%
Dec 30, 2012 -4.07%
Sep 30, 2012 -4.06%
Jul 1, 2012 -9.69%
Apr 1, 2012 -0.91%
Jan 1, 2012 6.92%
Oct 2, 2011 -1.97%
Jul 3, 2011 5.03%
Apr 3, 2011 6.30%
Jan 2, 2011 39.48%
Oct 3, 2010 3.20%
Jul 4, 2010 -3.73%
Apr 4, 2010 -16.77%
Jan 3, 2010 25.35%
Sep 27, 2009 -14.79%